Knockdown of c-MET induced apoptosis in ABCB1-overexpressed multidrug-resistance cancer cell lines
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Knockdown of c-MET induced apoptosis in ABCB1-overexpressed multidrug-resistance cancer cell lines
Authors
Keywords
-
Journal
CANCER GENE THERAPY
Volume 22, Issue 5, Pages 262-270
Publisher
Springer Nature
Online
2015-04-24
DOI
10.1038/cgt.2015.15
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Wnt pathway activation and ABCB1 expression account for attenuation of Proteasome inhibitor-mediated apoptosis in multidrug-resistant cancer cells
- (2015) Kowit Yu Chong et al. CANCER BIOLOGY & THERAPY
- Wnt5A regulates ABCB1 expression in multidrug-resistant cancer cells through activation of the non-canonical PKA/β-catenin pathway
- (2015) Tsai-Hsien Hung et al. Oncotarget
- FZD1 activates protein kinase C delta-mediated drug-resistance in multidrug-resistant MES-SA/Dx5 cancer cells
- (2014) Tsai-Hsien Hung et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Repositioning of Tyrosine Kinase Inhibitors as Antagonists of ATP-Binding Cassette Transporters in Anticancer Drug Resistance
- (2014) Yi-Jun Wang et al. Cancers
- Gene silencing of c-Met leads to brain metastasis inhibitory effects
- (2013) Se Jeong Lee et al. CLINICAL & EXPERIMENTAL METASTASIS
- Mechanisms of Drug Resistance in Cancer Chemotherapy: Coordinated Role and Regulation of Efflux Transporters and Metabolizing Enzymes
- (2013) Ramya Vadlapatla et al. CURRENT PHARMACEUTICAL DESIGN
- Inducible and constitutive HSP70s confer synergistic resistance against metabolic challenges
- (2012) Kowit Yu Chong et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Abnormal expression of E-cadherin in tumor cells is associated with poor prognosis of gastric carcinoma
- (2012) Yin Li et al. JOURNAL OF SURGICAL ONCOLOGY
- MET Activation Mediates Resistance to Lapatinib Inhibition of HER2-Amplified Gastric Cancer Cells
- (2012) C.-T. Chen et al. MOLECULAR CANCER THERAPEUTICS
- Interactions of N-desmethyl imatinib, an active metabolite of imatinib, with P-glycoprotein in human leukemia cells
- (2011) Petr Mlejnek et al. ANNALS OF HEMATOLOGY
- Knockdown of c-Met enhances sensitivity to bortezomib in human multiple myeloma U266 cells via inhibiting Akt/mTOR activity
- (2011) WENZHONG QUE et al. APMIS
- Sildenafil Reverses ABCB1- and ABCG2-Mediated Chemotherapeutic Drug Resistance
- (2011) Z. Shi et al. CANCER RESEARCH
- Silencing of c-Met by RNA interference inhibits the survival, proliferation, and invasion of nasopharyngeal carcinoma cells
- (2011) Yuncheng Li et al. TUMOR BIOLOGY
- Mechanisms of HGF/Met Signaling to Brk and Sam68 in Breast Cancer Progression
- (2011) Alessia Locatelli et al. Hormones & Cancer
- In the clinic: ongoing clinical trials evaluating c-MET-inhibiting drugs
- (2011) Neelesh Sharma et al. Therapeutic Advances in Medical Oncology
- An overview of the c-MET signaling pathway
- (2011) Shawna Leslie Organ et al. Therapeutic Advances in Medical Oncology
- Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib
- (2010) A. Haouala et al. BLOOD
- Adenovirus-Mediated SiRNA Targeting c-Met Inhibits Proliferation and Invasion of Small-Cell Lung Cancer (SCLC) Cells
- (2010) Zhao-Xia Wang et al. JOURNAL OF SURGICAL RESEARCH
- Prolonged Drug Selection of Breast Cancer Cells and Enrichment of Cancer Stem Cell Characteristics
- (2010) Anna Maria Calcagno et al. JNCI-Journal of the National Cancer Institute
- MCF-7/ADR cells (re-designated NCI/ADR-RES) are not derived from MCF-7 breast cancer cells: a loss for breast cancer multidrug-resistant research
- (2010) Weifeng Ke et al. MEDICAL ONCOLOGY
- Down-regulation of the HGF/MET autocrine loop induced by celecoxib and mediated by P-gp in MDR-positive human hepatocellular carcinoma cell line
- (2009) Roberto Mazzanti et al. BIOCHEMICAL PHARMACOLOGY
- PHA665752, a small-molecule inhibitor of c-Met, inhibits hepatocyte growth factor-stimulated migration and proliferation of c-Met-positive neuroblastoma cells
- (2009) Hal E Crosswell et al. BMC CANCER
- Differential Regulation of Drug Transporter Expression by Hepatocyte Growth Factor in Primary Human Hepatocytes
- (2009) M. Le Vee et al. DRUG METABOLISM AND DISPOSITION
- c-Met-targeted RNA interference inhibits growth and metastasis of glioma U251 cells in vitro
- (2009) Sheng-Hua Chu et al. JOURNAL OF NEURO-ONCOLOGY
- Down-Regulation of c-Met Expression Inhibits Human HCC Cells Growth and Invasion by RNA Interference
- (2009) Bin Xie et al. JOURNAL OF SURGICAL RESEARCH
- Targeting MET transcription as a therapeutic strategy in multiple myeloma
- (2008) Cornel J. Phillip et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search